Mindbio Therapeutics Corp. (TSE:MBIO)
CNQX:MBIO
Canadian Market

Mindbio Therapeutics Corp. (MBIO) Income Statement

9 Followers

Mindbio Therapeutics Corp. Income Statement

Last quarter (Q3 2024), Mindbio Therapeutics Corp.'s total revenue was AU$433.23K, an increase of Infinity% from the same quarter last year. In Q3, Mindbio Therapeutics Corp.'s net income was AU$76.82K. See Mindbio Therapeutics Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 23
Total Revenue
-
Cost of Revenue
-
Gross Profit
-
Operating Expense
AU$ 3.61M
Operating Income
AU$ -3.61M
Net Non Operating Interest Income Expense
AU$ 451.30K
Other Income Expense
AU$ -668.23K
Pretax Income
AU$ -4.29M
Tax Provision
-
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
AU$ -4.29M
Basic EPS
AU$ -0.04
Diluted EPS
AU$ -0.04
Basic Average Shares
AU$ 110.14M
Diluted Average Shares
AU$ 110.14M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
AU$ 3.61M
Net Income From Continuing And Discontinued Operation
AU$ -4.29M
Normalized Income
AU$ -3.15M
Interest Expense
-
EBIT
AU$ -3.84M
EBITDA
AU$ -3.84M
Currency in AUD

Mindbio Therapeutics Corp. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis